Register Login

IMMUNOME INC. (IMNM)

SymbolIMNM
NameIMMUNOME INC.
SectorUNDEFINED
RegionUNDEFINED
IndustryPharmaceutical Preparations
Address18702 N. CREEK PARKWAY, BOTHELL, WA 98011
Telephone610-321-3700
Fax—
Email—
Website—
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001472012
Description

None

2026-05-15 17:27

New Form SCHEDULE 13G/A - Immunome Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000919574-26-003480 <b>Size:</b> 11 KB

Read more
2026-05-15 17:22

New Form SCHEDULE 13G/A - Immunome Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001104659-26-062570 <b>Size:</b> 10 KB

Read more
2026-05-15 11:07

New Form SCHEDULE 13G/A - Immunome Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001897612-26-000495 <b>Size:</b> 9 KB

Read more
2026-05-15 09:17

New Form SCHEDULE 13G - Immunome Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000919574-26-003222 <b>Size:</b> 14 KB

Read more
2026-05-12 20:05

(30% Negative) IMMUNOME INC. (IMNM) Reports Q2 2026 Financial Results

Read more
2026-05-12 20:02

Immunome Reports First Quarter 2026 Financial Results and Provides Business Update

Read more
2026-05-05 20:00

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more
2026-04-29 11:30

Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors

Read more
2026-04-24 17:07

New Form ARS - Immunome Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001140361-26-016691 <b>Size:</b> 1 MB

Read more
2026-04-24 17:07

New Form DEFA14A - Immunome Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001140361-26-016689 <b>Size:</b> 7 MB

Read more